Browse studies

Find your next paid study

1 recruiting study matching your filters

211At-MABG in Adults With Advanced Neuroendocrine Cancers

Phase I dose escalation study of 211At-MABG in adults with advanced pheochromocytoma / paraganglioma (PPGL) or other NET-overexpressing cancers (as evidenced b…

PheochromocytomaParagangliomaNeuroendocrine Tumors+3 more

Estimated

~$10 – $6,250

University of PennsylvaniaNCT07661420